Theriva Biologics Disclosed Positive Topline Data From Investigator Sponsored Phase 1 Trial Of Intravitreal VCN-01 In Pediatric Patients With Refractory Retinoblastoma
Theriva Biologics 披露了研究人員贊助的針對難治性視網膜母細胞瘤兒科患者的玻璃體內 VCN-01 的 1 期試驗的積極數據
Theriva Biologics Disclosed Positive Topline Data From Investigator Sponsored Phase 1 Trial Of Intravitreal VCN-01 In Pediatric Patients With Refractory Retinoblastoma
Theriva Biologics 披露了研究人員贊助的針對難治性視網膜母細胞瘤兒科患者的玻璃體內 VCN-01 的 1 期試驗的積極數據
使用瀏覽器的分享功能,分享給你的好友吧